1. HBW Insight
  2. >>Beauty
  3. >>Business
  4. >>Earnings

Takeda suffers OTC decline

Takeda reported Consumer Healthcare sales down by 4.9% to ¥79.0 billion (€614 million) in its financial year ended 31 March 2018, reflecting the loss of the rights to distribute Taisho’s Biofermin OTC products in Japan.

Takeda reported Consumer Healthcare sales down by 4.9% to ¥79.0 billion (€614 million) in its financial year ended 31 March 2018, reflecting the loss of the rights to distribute Taisho’s Biofermin OTC products in Japan.

Noting that it had stopped distributing Biofermin in Japan on 30 September 2017, Takeda said as a result, its sales...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Earnings

Ulta ‘Beauty Unleashed’ Investment Delivers In Fiscal Q1

 
• By Eileen Francis

Retailer Ulta Beauty, Inc. reports net sales in the fiscal first quarter beat consensus estimates, rising 4.5% to $2.85bn, as the company sees benefits of its recently announced ‘Beauty Unleashed’ initiative.

E.l.f. Plans To Acquire Hailey Bieber Beauty Brand For $1Bn

 
• By Eileen Francis

E.l.f. Beauty, Inc. has agreed to acquire celebrity and model Hailey Bieber’s rhode lifestyle beauty brand for $1bn, the firm reported during a 28 May fiscal fourth quarter earnings call, during which it also announced plans to raise product prices to ‘partially’ mitigate the impact of tariffs.

Shiseido’s Key Priorities: Recover Drunk Elephant, Accelerate NARS Amid US Prestige Slowdown

 
• By Eileen Francis

Shiseido’s Drunk Elephant premium skin care range – acquired in 2019 – and its NARS brand dragged sales in the Americas region down almost 20% in the first quarter, the firm reported in a 12 May earnings presentation.

IFF Offsets Tariffs’ Impact, But Discretionary Product Ingredients Face Risk

 
• By Eileen Francis

New York-based International Flavors & Fragrance, Inc. has shifted procurement to alternative supply sources and is balancing production across its global network in response to US tariffs, though company executives say ingredients for discretionary products face risk.

More from Business